Walvax Biotechnology Co., Ltd. (300142.SZ)
Develops and makes vaccines for diseases like pneumonia, meningitis, and HPV in China.
12.19+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-3.1%
The outlook
Walvax Biotechnology trades well below both its 50- and 200-day moving averages, sitting near the lower end of its 52-week range. Analyst targets average 34% below the current price, and the stock carries a high trailing P/E of 67.7, reflecting thin profitability relative to valuation. Overall sentiment leans bearish based on current technical and fundamental positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range24% of the way from its 52-week low to high
Price targetAvg target -34% vs current price
Market cap
$19.50B
52-wk high
16.23
52-wk low
10.88
50-day avg
12.74
200-day avg
12.35
Trailing P/E
67.7
Similar stocks
300122.SZChongqing Zhifei Biological Products Co., Ltd.$12.63+0.88%300601.SZShenzhen Kangtai Biological Products Co., Ltd.$12.28+1.82%002007.SZHualan Biological Engineering Inc.$13.26+2.24%300347.SZHangzhou Tigermed Consulting Co., Ltd$50.78+5.66%300015.SZAier Eye Hospital Group Co., Ltd.$8.87+2.90%